Serialization in Pharma Manufacturing: Regulations, Implementation, and Best Practices

Serialization in Pharma Manufacturing: Regulations, Implementation, and Best Practices

Table of Contents

TL;DR

Regulations such as DSCSA and EU FMD require every marketable pharmaceutical unit to carry a unique, traceable identifier, but serialization accuracy depends on clean data starting upstream in production, not just the packaging line. A connected MES data layer closes the gap between live production and accurate serialization by feeding consistent batch, lot, and expiry data into the systems that need it.

Key takeaways:

  • Serialization assigns unique identifiers to each sellable unit, while aggregation links those serial numbers to case and pallet identifiers to create a verifiable hierarchy.
  • DSCSA and EU FMD both require package-level identification verified at key supply chain handoffs.
  • Serialization data originates across separate systems, ERP, MES, and serialization databases, and disconnected sources introduce errors that cause rejected returns, failed transactions, and line stoppages.
  • An MES like TrakSYS captures batch, lot, and genealogy data in real-time and serves as a single, accurate data source for ERP and serialization systems.

Want to hear more about how TrakSYS supports clean, connected serialization with real-time data capture? Book a meeting here.

Clean Labeling Starts with Clean Production Data

Global regulations such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD) require every marketable pharmaceutical unit to carry a unique, traceable identifier, such as a barcode or serial number. These regulations affect pharmaceutical manufacturers, suppliers, and distributors alike. Organizations that don’t properly serialize risk rejections, shipment holds, and compliance nonconformance.

Serialization is typically approached as a packaging-line problem, meaning something that can be solved with the right printing or labeling. But the accuracy of serialization data (GTIN, batch, lot, expiration, etc.) starts farther upstream on the production floor—long before barcodes are printed on packaging lines.

A strong data foundation, created by a connected MES-supported data layer, can close the gap between live production and accurate serialization.

What Do Serialization and Aggregation Mean in Pharmaceuticals?

Serialization assigns a unique identifier, typically a GS1 GTIN plus a serial number, to each sellable unit, enabling track-and-trace capabilities from creation through distribution. This is different from lot-level traceability, which groups products by batch rather than by individual units.

Aggregation builds on top of lot-level identification, linking serial numbers to case and pallet identifiers to create a hierarchy that’s readily verifiable by regulators or trading partners. Its goal is patient safety by stopping counterfeit, diverted, or substandard drugs from reaching patients undetected.

What do DSCSA, EU FMD, and other Emerging Regulations Require?

Regulation varies by market, but core pillars are consistent: package-level identification, verified at key handoff points throughout the supply chain.

Layer What it Governs Example
IPC (A-610 / J-STD-001) Quality and process documentation Verified solder joint acceptance criteria and process records
ITAR/EAR Access to controlled technical data Restricting non-U.S. person access to defense-related work instructions
Customer-specific specs Contract-defined format and granularity Lot-tracking depth or retention periods unique to a specific OEM contract

Most notably, recent DSCSA wholesale distributor requirements eliminated the FDA stabilization period and began enforcing electronic, package-level traceability. Large dispensers were required to comply by November 2025, and small dispensers are to follow in November 2026.

As opposed to a single regulation, multi-market manufacturers must reconcile overlapping and sometimes conflicting data and reporting requirements across jurisdictions. Plus, serialization doesn’t exist in isolation from manufacturers’ other compliance efforts. It sits within a wider set of GMP, 21 CFR Part 11, and EU Annex 11 obligations.

Why Does Serialization Break Down at the Data Layer?

A serialized barcode carries only the data fed to it, and the data often originates from various systems: ERP for GTIN; MES for batch, lot, and expiry; and a dedicated serialization database for serial number ranges.

When such source systems aren’t connected, manual data entry and system reconciliation are necessary and can introduce errors that cause rejected returns, failed EPCIS transactions, and line stoppages. For instance, packaging-line serialization equipment could encode data perfectly and still produce an incorrect label if it lacks visibility into the correct batch, lot, or expiration data.

Most serialization solutions simplify labeling and aggregation complexities, but aren’t positioned to address upstream data integrity issues that determine whether the end labels are correct.

Serialization System Implementation Considerations

Strong data management comes first. GTIN, batch, lot, and expiry data must be clean and synchronized across ERP, MES, and the serialization layer.

Integration architecture matters nearly as much as the data itself. Mapping exactly how data flows between each layer prevents surprises once the system goes live.

Exception handling is also best addressed before go-live. Building workflows to handle mismatched or missing data ahead of launch can help prevent line stoppages and rejected shipments.

Trading partner testing, via coordinated piloting of serialized data exchange with distributors and downstream partners, should occur well ahead of enforcement deadlines.

Lastly, change management efforts should extend beyond IT and packaging engineers; the operators who run the systems every day need appropriate training on their new digital workflows.

What Are Common Serialization Pitfalls?

A few key mistakes recur across serialization implementations, and most of them stem from treating the project too narrowly:

  • Serialization is often scoped as a standalone packaging-line project instead of an enterprise data initiative spanning ERP, MES, and packaging.
  • The master data cleanup required before serialization systems can function tends to be underestimated, pushing problems downstream into production.
  • The volume of exceptions across systems is often miscalculated—missing or mismatched data at scale can quickly overwhelm manual review processes.

How Does an MES Data Layer Feed Clean Data to Serialization Systems?

A dynamic MES like TrakSYS captures batch, lot, expiry, and genealogy data in real-time across production—long before the data ever reaches a downstream serialization system.

Rather than replacing dedicated serialization or aggregation platforms, the MES acts as the connective data layer between ERP, production, and serialization equipment. This ensures that every system references a single, accurate data source.

Digital batch management eliminates manual, paper-based record transcription, a leading source of errors in serialization data. When data is captured in real-time, serial number assignments reflect what’s actually happening on the production line, not a manually reconciled estimate.

This capability positions MES as an infrastructural tool that makes serialization systems more reliable, not a competing product; the strongest serialization implementations pair a dedicated serialization solution with an MES to supply accurate data.

Implementation Example:

Consider a drug manufacturer running serialization across three packaging lines, and they had recurring EPCIS transaction failures traced back to batch and expiration data that didn’t match between their ERP and serialization database. After connecting production execution using an MES, batch and lot information automatically flowed into the serialization system at the point of packaging, thus eliminating the manual reconciliation step that had been introducing inaccurate data entries.

Conclusion

Today, serialization compliance is a baseline operating requirement across major pharmaceutical markets. The systems most likely to struggle are the ones running without a clean, connected source of production data. A real-time MES data layer strengthens serialization, traceability, and broader GMP compliance in one unified platform.

Manufacturers evaluating serialization readiness should start by auditing the origins and accuracy of their batch, lot, and expiry data.

Want to hear more about how TrakSYS supports clean, connected serialization with real-time data capture? Book a meeting here.

FAQs

What's the difference between serialization and aggregation?
Does an MES replace dedicated serialization software?
Why can packaging-line equipment encode data correctly yet still produce an incorrect label?
What's the first step manufacturers should take when evaluating serialization readiness?

Related Blog Posts

Let’s Build Your Plan

We’ll help you create the right configuration—today and for the future.